Lupin Limited has informed the Exchange regarding a press release dated September 24, 2025, titled ""Lupin Receives Tentative Approval from U.S. FDA for Bictegravir, Emtricitabine, andTenofovir Alafenamide Tablets"".
FILING COMPLAINTS ON SCORES - EASY & QUICK a. Register on SCORES portal b. Mandatory details for filing complaints on SCORES: i. Name, PAN, Address, Mobile Number, E-mail ID c. Benefits: i. Effective communication ii. Speedy redressal of the grievances SEBI : https://scores.sebi.gov.in